Robin E. Munro
Wishaw, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.
Journal: JAMA
Published: May 14, 2026
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.
Journal: Calcified tissue international
Published: July 05, 2025
Advancing real-world research in thoracic malignancies: learnings from the international I-O Optimise initiative.
Journal: Future oncology (London, England)
Published: February 25, 2025
Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018.
Journal: BMC pulmonary medicine
Published: August 09, 2022
Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis.
Journal: BMC cancer
Published: June 28, 2021
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
Journal: BMC pulmonary medicine
Published: April 30, 2020
I-O Optimise: a novel multinational real-world research platform in thoracic malignancies.
Journal: Future oncology (London, England)
Published: March 12, 2019
Reasonable adjustments to provide equitable and inclusive assessment, screening and treatment of osteoporosis for adults with intellectual disabilities: A feasibility study.
Journal: Journal of applied research in intellectual disabilities : JARID
Published: April 06, 2018
The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank.
Journal: BMC musculoskeletal disorders
Published: July 07, 2016
The Veterinary Forensic Necropsy: A Review of Procedures and Protocols.
Journal: Veterinary pathology
Published: July 03, 2016
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial.
Journal: Lancet (London, England)
Published: May 21, 2016
Last Updated: 09/26/2026